Actuate Therapeutics, Inc. - Common stock (NQ:ACTU)

5.750 -0.390 (-6.35%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist

Price and Volume

Volume	95,323
Open	6.150
Bid (Size)	5.710 (100)
Ask (Size)	5.750 (600)
Prev. Close	6.140
Today's Range	5.680 - 6.200
52wk Range	5.470 - 11.99
Shares Outstanding	23,243,328
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer ↗

September 22, 2025

Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 10, 2025

Via Benzinga

Performance

YTD	-4.6%	-4.6%
1 Month	-16.2%	-16.2%
3 Month	-28.9%	-28.9%
6 Month	-7.3%	-7.3%
1 Year	-28.8%	-28.8%

More News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 09, 2025

Via Benzinga

This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗

August 26, 2025

Via Benzinga

Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy

August 25, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 26, 2025

Via Benzinga

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗

January 28, 2025

Via Benzinga

Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

December 13, 2024

Via Benzinga

Pheton, Powell Max Make Public Debut ↗

September 08, 2024

Via Talk Markets

Actuate Therapeutics Makes Public Debut ↗

August 18, 2024

Via Talk Markets

InvestorNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering

August 15, 2024

Via Investor Brand Network

Frequently Asked Questions

Is Actuate Therapeutics, Inc. - Common stock publicly traded?

Yes, Actuate Therapeutics, Inc. - Common stock is publicly traded.

What exchange does Actuate Therapeutics, Inc. - Common stock trade on?

Actuate Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Actuate Therapeutics, Inc. - Common stock?

The ticker symbol for Actuate Therapeutics, Inc. - Common stock is ACTU on the Nasdaq Stock Market

What is the current price of Actuate Therapeutics, Inc. - Common stock?

The current price of Actuate Therapeutics, Inc. - Common stock is 5.750

When was Actuate Therapeutics, Inc. - Common stock last traded?

The last trade of Actuate Therapeutics, Inc. - Common stock was at 01/12/26 04:00 PM ET

What is the market capitalization of Actuate Therapeutics, Inc. - Common stock?

The market capitalization of Actuate Therapeutics, Inc. - Common stock is 133.65M

How many shares of Actuate Therapeutics, Inc. - Common stock are outstanding?

Actuate Therapeutics, Inc. - Common stock has 134M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.